Search results
Results from the WOW.Com Content Network
The prognosis for acute myeloid leukemia varies depending on age, subtype, and response to treatment. The best survival is in patients under age 20, with a five-year survival rate of 68%. For people 20 and older, the five-year survival rate is 26%.
There are two sides of the coin in acute myeloid leukemia prognoses. One side is complete remission. The other is recurrence, when AML comes back: Overall, an estimated 50% to 80% of people with acute myeloid leukemia achieve complete remission after treatment. Complete remission happens more often in children and people under age 60.
Acute myelogenous leukemia is most common in adults age 65 and older. Prior cancer treatment. People who've had certain types of chemotherapy and radiation therapy may have a greater risk of AML.
According to the American Cancer Society (ACS), around 90 percent of people with an AML type known as acute promyelocytic leukemia (APL) will go into remission after “induction” (first round) of...
According to the National Cancer Institute, about 30 percent of people diagnosed with AML survive 5 years or longer. When receiving an AML diagnosis, it’s also important to discuss...
Acute myeloid leukemia (AML) is a rapid and aggressive form of leukemia. While medical advancements have improved survival rates, AML remains a formidable disease. The overall 5-year relative...
Since the 2017 report from the European LeukemiaNet (ELN), 1 there has been substantial progress in our knowledge of acute myeloid leukemia (AML). Recent advances significantly influence clinical practice.
Prognosis estimates the outcome for acute myeloid leukemia (AML). It depends on many factors including subtype, chromosome changes and your age.
Acute myeloid leukemia (AML) is a fast-growing form of cancer of the blood and bone marrow. AML is the most common type of acute leukemia. AML is also known as acute myelogenous leukemia, acute myeloblastic leukemia, acute granulocytic leukemia or acute nonlymphocytic leukemia.
AML is fast growing. The leukemia cells enter the blood quickly and sometimes can spread to the liver, spleen, central nervous system (brain and spinal cord), and testicles. There are many different types of AML. In some, the AML cells have gene changes that can affect how well treatment works.